These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3135775)

  • 21. Residual virulence of Brucella abortus in the absence of the cytochrome bc(1)complex in a murine model in vitro and in vivo.
    Ko J; Splitter GA
    Microb Pathog; 2000 Sep; 29(3):191-200. PubMed ID: 10968951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular trafficking study of a RB51 B. abortus vaccinal strain isolated from cow milk.
    Arellano-Reynoso B; Díaz-Aparicio E; Leal-Hernández M; Hernández L; Gorvel JP
    Vet Microbiol; 2004 Mar; 98(3-4):307-12. PubMed ID: 15036539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella abortus nicotinamidase (PncA) contributes to its intracellular replication and infectivity in mice.
    Kim S; Kurokawa D; Watanabe K; Makino S; Shirahata T; Watarai M
    FEMS Microbiol Lett; 2004 May; 234(2):289-95. PubMed ID: 15135535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the urease operon of Brucella abortus and assessment of its role in virulence of the bacterium.
    Sangari FJ; Seoane A; Rodríguez MC; Agüero J; García Lobo JM
    Infect Immun; 2007 Feb; 75(2):774-80. PubMed ID: 17101645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Course of chronic brucellosis in mice is not improved by administration of a vaccinal antigen].
    Plommet M; Plommet AM; Bosseray N
    Ann Rech Vet; 1982; 13(2):127-32. PubMed ID: 6820248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of HdeA in acid resistance and virulence in Brucella abortus 2308.
    Valderas MW; Alcantara RB; Baumgartner JE; Bellaire BH; Robertson GT; Ng WL; Richardson JM; Winkler ME; Roop RM
    Vet Microbiol; 2005 May; 107(3-4):307-12. PubMed ID: 15863292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
    Cabrera A; Sáez D; Céspedes S; Andrews E; Oñate A
    Immunobiology; 2009; 214(6):467-74. PubMed ID: 19150742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.
    Spera JM; Ugalde JE; Mucci J; Comerci DJ; Ugalde RA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16514-9. PubMed ID: 17053080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid raft microdomains mediate class A scavenger receptor-dependent infection of Brucella abortus.
    Kim S; Watarai M; Suzuki H; Makino S; Kodama T; Shirahata T
    Microb Pathog; 2004 Jul; 37(1):11-9. PubMed ID: 15194155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
    Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
    Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The defect in the metabolism of erythritol of the Brucella abortus B19 vaccine strain is unrelated with its attenuated virulence in mice.
    Sangari FJ; Grilló MJ; Jiménez De Bagüés MP; González-Carreró MI; García-Lobo JM; Blasco JM; Agüero J
    Vaccine; 1998 Oct; 16(17):1640-5. PubMed ID: 9713940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the pathogenicity of nonstable Brucella L-forms and their revertants.
    Grekova NA; Tolmacheva TA; Vershilova PA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):129-34. PubMed ID: 119809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments.
    Pizarro-Cerdá J; Moreno E; Sanguedolce V; Mege JL; Gorvel JP
    Infect Immun; 1998 May; 66(5):2387-92. PubMed ID: 9573138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemical basis of the virulence of Brucella abortus. VII. The production in vitro of organisms with an enhanced capacity to survive intracellularly in bovine phagocytes.
    Fitzgeorge RB; Smith H
    Br J Exp Pathol; 1966 Dec; 47(6):558-62. PubMed ID: 4959298
    [No Abstract]   [Full Text] [Related]  

  • 35. [Brucella L-forms, their revertants and initial cultures].
    Taran IF; Tsybin BP; Krylova AA; Abolina TA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):39-43. PubMed ID: 6794254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolite-resistance and virulence of smooth Brucella variants isolated after prolonged cultivation.
    GOODLOW RJ; BRAUN W; MIKA LA
    Proc Soc Exp Biol Med; 1951 Apr; 76(4):786-8. PubMed ID: 14844350
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.
    Wang X; Li Z; Li B; Chi H; Li J; Fan H; Yao R; Li Q; Dong X; Chen M; Qu H; Wang Y; Gao W; Wang Y; Sun Y; Sun R; Qian J; Xia Z
    Mol Imaging Biol; 2016 Aug; 18(4):519-26. PubMed ID: 26846129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What have we learned from brucellosis in the mouse model?
    Grilló MJ; Blasco JM; Gorvel JP; Moriyón I; Moreno E
    Vet Res; 2012 Apr; 43(1):29. PubMed ID: 22500859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.
    Allen CA; Adams LG; Ficht TA
    Infect Immun; 1998 Mar; 66(3):1008-16. PubMed ID: 9488389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence of Brucella: bacterial growth and decline in mice.
    Plommet M; Plommet AM
    Ann Rech Vet; 1988; 19(1):65-7. PubMed ID: 3135775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.